CUMULUS ONCOLOGY LIMITED

Active Edinburgh

Research and experimental development on biotechnology

20 employees website.com
Life sciences and medical technology Research and experimental development on biotechnologyOther research and experimental development on natural sciences and engineering
C

CUMULUS ONCOLOGY LIMITED

Research and experimental development on biotechnology

Founded 13 Nov 2017 Active Edinburgh, Scotland 20 employees website.com
Life sciences and medical technology Research and experimental development on biotechnologyOther research and experimental development on natural sciences and engineering
Accounts Submitted 7 Jan 2026 Next due 30 Sept 2026 5 months remaining
Confirmation Submitted 13 Nov 2025 Next due 26 Nov 2026 7 months remaining
Net assets £6M £4M 2024 year on year
Total assets £6M £4M 2024 year on year
Total Liabilities £450K £192K 2024 year on year
Charges 1
1 outstanding

Contact & Details

Contact

Registered Address

61 Dublin Street Edinburgh Midlothian EH3 6NL Scotland

Email

info@example.com

Website

www.example.com

Full company profile for CUMULUS ONCOLOGY LIMITED (SC581311), an active life sciences and medical technology company based in Edinburgh, Scotland. Incorporated 13 Nov 2017. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2018–2024)

Cash in Bank

£3.47M

Decreased by £3.54M (-51%)

Net Assets

£5.95M

Decreased by £3.73M (-39%)

Total Liabilities

£450.12k

Increased by £191.88k (+74%)

Turnover

N/A

Employees

20

Increased by 7 (+54%)

Debt Ratio

7%

Increased by 4 (+133%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 3

Investors (3)

Investor NameInvestor SinceParticipating Rounds
Investor 1Jan 2024Seed
Investor 2Jan 2024Seed
Investor 3Jan 2024Seed

Share Capital

Share Capital

Share allotments and capital structure

6 Allotments 51,124 Shares £14.82m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
6 Feb 20265,336£53.36£0.01
20 Dec 202323,698£9.00m£379.73
16 Feb 20227,850£2.50m£318.47
16 Feb 20225,094£1.62m£318.47
9 Jun 20206,746£1.70m£252.18

Officers

Officers

2 active 1 resigned
Status
Brian Michael Gallagher JrDirectorAmericanUnited States569 Dec 2024Active
Clare Jane WareingDirectorBritishUnited Kingdom6213 Nov 2017Active

Shareholders

Shareholders (118)

Scottish Investments Limited
26.8%
15,800
Dr Clare Jane Wareing
17.1%
10,081

Persons with Significant Control

Persons with Significant Control (1)

1 Active 2 Ceased

Scottish National Investment Bank Plc

Unknown

Active
Notified 7 Mar 2025
Nature of Control
  • Ownership Of Shares 25 To 50 Percent
Ceased

Clare Jane Wareing

Ceased 20 Dec 2023

Ceased

Group Structure

Group Structure

CUMULUS ONCOLOGY LIMITED Current Company
NODUS ONCOLOGY LIMITED united kingdom

Charges

Charges

1 outstanding

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
9 Feb 2026ResolutionResolutions
9 Feb 2026IncorporationMemorandum Articles
6 Feb 2026CapitalAllotment of shares (GBP 642.78) on 2026-02-06
7 Jan 2026AccountsAnnual accounts made up to 2024-12-31
13 Nov 2025Confirmation StatementConfirmation statement made on 2025-11-12 with no updates
9 Feb 2026 Resolution

Resolutions

9 Feb 2026 Incorporation

Memorandum Articles

6 Feb 2026 Capital

Allotment of shares (GBP 642.78) on 2026-02-06

7 Jan 2026 Accounts

Annual accounts made up to 2024-12-31

13 Nov 2025 Confirmation Statement

Confirmation statement made on 2025-11-12 with no updates

Recent Activity

Latest Activity

Resolutions

2 months ago on 9 Feb 2026

Memorandum Articles

2 months ago on 9 Feb 2026

Allotment of shares (GBP 642.78) on 2026-02-06

2 months ago on 6 Feb 2026

Annual accounts made up to 2024-12-31

3 months ago on 7 Jan 2026

Confirmation statement made on 2025-11-12 with no updates

5 months ago on 13 Nov 2025